CytomX Therapeutics, Inc. (CTMX)
4.30
+0.16
(+3.86%)
USD |
NASDAQ |
Jan 07, 16:00
4.295
0.00 (0.00%)
After-Hours: 20:00
CytomX Therapeutics Price: 4.30 for Jan. 7, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| BioMarin Pharmaceutical, Inc. | 61.31 |
| NovaBay Pharmaceuticals, Inc. | 10.64 |
| Palatin Technologies, Inc. | 17.46 |
| Theriva Biologics, Inc. | 0.2227 |
| Oragenics, Inc. | 0.8802 |
Price Related Metrics
| PE Ratio | 10.28 |
| PS Ratio | 4.364 |
| PEG Ratio | 0.0701 |
| Price to Book Value | 6.784 |
| Earnings Yield | 9.73% |
| Market Cap | 728.57M |
| PEGY Ratio | 0.0701 |
| Operating PE Ratio | 21.43 |
| Normalized PE Ratio | 10.29 |